<DOC>
	<DOC>NCT02245724</DOC>
	<brief_summary>The purpose of this study was to analyze the benefit of autologous mononuclear cell therapy in mental retardation.</brief_summary>
	<brief_title>Stem Cell Therapy in Mental Retardation</brief_title>
	<detailed_description />
	<mesh_term>Intellectual Disability</mesh_term>
	<criteria>diagnosed cases of mental retardation age above 6 months presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus malignancies bleeding tendencies pneumonia renal failure severe liver dysfunction severe anemia [Hemoglobin &lt; 8] any bone marrow disorder space occupying lesion in brain other acute medical conditions such as respiratory infection and pyrexia</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Mental retardation</keyword>
	<keyword>Autologous mononuclear cell therapy</keyword>
	<keyword>Stem cell</keyword>
</DOC>